MDS Sequencing Project_Cancer Cell
Myelodysplastic syndromes (MDS) are uncommon entities, heterogeneous clinically and cytogenetically. The aim of the present study is to determine genetic alteration in this subset of patients. Expected results: Identification of new aberrations and genetic markers in order to detect novel genes involved in MDS 5q-response to Lenalidomide's treatment.
- Type: Other
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00001001058 | Illumina HiSeq 2000 | 42 |
Publications | Citations |
---|---|
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.
Cancer Cell 26: 2014 509-520 |
115 |